
Sign up to save your podcasts
Or


U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.2
386386 ratings
U.S. officials bet on Novavax to provide a shot that could easily be shipped overseas. But its manufacturing problems have left global distributors without enough shots for poor and middle-income countries. POLITICO's Erin Banco reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices

4,225 Listeners

3,447 Listeners

609 Listeners

617 Listeners

1,523 Listeners

455 Listeners

707 Listeners

724 Listeners

963 Listeners

307 Listeners

108 Listeners

291 Listeners

206 Listeners

5,217 Listeners

2,592 Listeners

141 Listeners

153 Listeners

41 Listeners

718 Listeners

496 Listeners

266 Listeners

146 Listeners

12 Listeners